This HTML5 document contains 68 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q64601594
rdf:type
wikibase:Item
schema:description
klinisch onderzoek клінічне випробування ensayu clínicu clinical trial
rdfs:label
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
skos:prefLabel
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
schema:name
A Study of Carboplatin, Pemetrexed Plus Placebo vs Carboplatin, Pemetrexed Plus 1 or 2 Truncated Courses of Demcizumab in Subjects With Non-Squamous Non-Small Cell Lung Cancer
p:P1476
wds:Q64601594-FA2E0CD3-08F6-4B7C-915E-90CA58DBB109
wdt:P1476
A 2-Arm Phase 2 Double-Blind Randomized Study of Carboplatin, Pemetrexed Plus Placebo Versus Carboplatin, Pemetrexed Plus Truncated Demcizumab as First-Line Treatment in Subjects With Stage IV Non-Squamous Non-Small Cell Lung Cancer
p:P582
wds:Q64601594-083DF151-17DC-41E6-BBB1-12DC16544628
wdt:P582
2017-04-07T00:00:00Z
p:P31
wds:Q64601594-A11574A6-0070-473D-B34A-BC99A7998BD0
wdt:P31
wd:Q30612
p:P580
wds:Q64601594-3463AA71-9E18-4C48-8107-92EE5BFD02F7
wdt:P580
2015-02-01T00:00:00Z
p:P17
wds:Q64601594-EBF7D707-11AE-4188-B38C-FDEE4FA45CB6 wds:Q64601594-DBE49E6D-D25A-44DC-BD0F-9660761C040F wds:Q64601594-9B4B4B80-30CA-442A-AA2B-F259F3AB08B7 wds:Q64601594-3F8B4357-8BF9-4A92-A6AD-9319A0AEDE47 wds:Q64601594-1CFB0EC6-BB37-40FB-B5EC-42B616D62CB6
wdt:P17
wd:Q29 wd:Q30 wd:Q408 wd:Q38 wd:Q31
p:P6153
wds:Q64601594-0FB8C361-5B92-40CC-845E-1CE0D18894E3 wds:Q64601594-14C2901F-04E9-4584-97DD-E3B7E3509749 wds:Q64601594-B3E30F9F-BD7B-4D2B-BC76-60D08F4E6ADE wds:Q64601594-CE372C4E-2E96-421B-866B-0C835D849DE0 wds:Q64601594-E44BA481-162E-45A8-B0D4-0513DA7F271E wds:Q64601594-2A53BA44-29C2-46FE-BF37-C25503128B31 wds:Q64601594-3951AAE1-B597-45BE-A9C7-19EC7A5F49BA wds:Q64601594-54F21787-26E4-4F93-BAF4-46D95D3F2282 wds:Q64601594-68427655-9951-4790-AD56-BA928D2AD96B wds:Q64601594-7CC84D72-E944-42B5-AD10-D49507852331 wds:Q64601594-A0594194-FEE7-4A78-9608-62A3ABFB5F91 wds:Q64601594-A1BBFE7E-0FD7-432C-BA26-DA124D345D18 wds:Q64601594-0691DFAF-5ADD-4F8D-9AAB-5B4A18FBC218
wdt:P6153
wd:Q30282252 wd:Q812573 wd:Q5721418 wd:Q30279623 wd:Q2371388 wd:Q30269842 wd:Q1047060 wd:Q7270336 wd:Q1061104 wd:Q219694 wd:Q3145371 wd:Q2725999 wd:Q7370121
p:P1813
wds:Q64601594-A917EEE2-957A-4677-9D40-3A0B44347F9B
wdt:P1813
DENALI
p:P4844
wds:Q64601594-BFEACE51-349A-4A43-82C2-E0A9852A18E6 wds:Q64601594-63B513C7-0A2D-4F5E-AD5F-89F565C83995
wdt:P4844
wd:Q415588 wd:Q415220
p:P2899
wds:Q64601594-E85FECD2-CE3A-4E18-97AF-8F05B885B4BD
wdt:P2899
21
p:P1132
wds:Q64601594-009FEDE6-46A6-478C-A949-6EDB248027BE
wdt:P1132
82
p:P8363
wds:Q64601594-1827805F-BFE3-4710-9F8C-F405A790A022
wdt:P8363
wd:Q78089383
p:P3098
wds:Q64601594-466D7D59-6631-4246-A5CA-246EB0D4B711
wdt:P3098
NCT02259582
p:P6099
wds:Q64601594-A7CE2EB5-5AE9-4BF0-BDBE-90C2F1B462A5
wdt:P6099
wd:Q42824440